China's AIM Vaccine surges on share buyback plan

AIM Vaccine

24/10/2023 08:50

** Shares of AIM Vaccine  6660.HK  jump as much as 19.3% to
HK$10.24 after co announces share buyback plan
    ** Stock on course for the biggest one-day pct rise since
March 13 if gains hold; third-biggest pct gainer in Hang Seng
Composite Index  .HSCI 
    ** Vaccine maker says it plans to repurchase up to 49.2 mln
H shares in the open market, representing 10% of total H shares
    ** Co says its operations, financial positions and sales of
existing products are normal, and the research and development
of pipeline vaccine candidates are progressing as planned
    ** Hong Kong's healthcare index  .HSCIH  rises 1.4%, while
Hang Seng Composite Index eases 0.7%, Hang Seng Index  .HSI 
down 0.9%
    ** Stock down 58.6% YTD

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))